Shares of Select Medical Holdings Corporation (NYSE:SEM - Get Free Report) saw an uptick in trading volume on Wednesday . 3,406,739 shares traded hands during mid-day trading, an increase of 95% from the previous session's volume of 1,748,550 shares.The stock last traded at $16.4550 and had previously closed at $16.45.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on SEM. Benchmark cut shares of Select Medical from a "buy" rating to a "hold" rating in a report on Wednesday, March 4th. Wall Street Zen cut shares of Select Medical from a "buy" rating to a "hold" rating in a report on Monday, March 9th. Royal Bank Of Canada reaffirmed a "sector perform" rating and issued a $16.50 price target (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Weiss Ratings raised shares of Select Medical from a "sell (d+)" rating to a "hold (c-)" rating in a report on Friday, February 20th. Finally, Zacks Research cut shares of Select Medical from a "hold" rating to a "strong sell" rating in a report on Thursday, February 26th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $15.63.
Get Our Latest Stock Analysis on Select Medical
Select Medical Price Performance
The firm has a market capitalization of $2.04 billion, a PE ratio of 14.31, a price-to-earnings-growth ratio of 0.94 and a beta of 1.12. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.04 and a current ratio of 1.04. The business's 50 day moving average is $16.12 and its two-hundred day moving average is $15.20.
Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, February 19th. The health services provider reported $0.16 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by ($0.07). Select Medical had a net margin of 2.68% and a return on equity of 7.26%. The business had revenue of $1.40 billion during the quarter, compared to analysts' expectations of $1.36 billion. During the same quarter in the prior year, the firm posted $0.18 earnings per share. The firm's quarterly revenue was up 6.4% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities research analysts anticipate that Select Medical Holdings Corporation will post 1.27 earnings per share for the current fiscal year.
Select Medical Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 12th. Investors of record on Monday, March 2nd were paid a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date was Monday, March 2nd. Select Medical's payout ratio is currently 21.74%.
Select Medical declared that its board has authorized a share repurchase plan on Thursday, February 19th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the health services provider to purchase up to 49.5% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's management believes its shares are undervalued.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of SEM. Smartleaf Asset Management LLC grew its position in shares of Select Medical by 37.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider's stock valued at $43,000 after purchasing an additional 788 shares in the last quarter. State of Alaska Department of Revenue grew its position in shares of Select Medical by 1.5% during the 4th quarter. State of Alaska Department of Revenue now owns 63,370 shares of the health services provider's stock valued at $940,000 after purchasing an additional 935 shares in the last quarter. Wilmington Savings Fund Society FSB grew its position in shares of Select Medical by 20.9% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider's stock valued at $74,000 after purchasing an additional 999 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH grew its position in shares of Select Medical by 9.7% during the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 11,475 shares of the health services provider's stock valued at $171,000 after purchasing an additional 1,014 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund grew its position in shares of Select Medical by 5.1% during the 3rd quarter. Oregon Public Employees Retirement Fund now owns 24,816 shares of the health services provider's stock valued at $319,000 after purchasing an additional 1,200 shares in the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.
Select Medical Company Profile
(
Get Free Report)
Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.
Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.